NCT00124241View on ClinicalTrials.gov

An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Primary Completion Date

February 28, 2003

Study Completion Date

November 30, 2005

Conditions

Hepatitis B

Interventions

DRUG

telbivudine

DRUG

lamivudine

Trial Locations (4)

Unknown

Los Angeles

Toronto

Hong Kong

Paris

Sponsors

Lead Sponsor

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Novartis

INDUSTRY

NCT00124241 - An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B | Biotech Hunter | Biotech Hunter